Bay Capital Advisors LLC Buys New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bay Capital Advisors LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,089 shares of the medical equipment provider’s stock, valued at approximately $568,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Proficio Capital Partners LLC increased its position in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after acquiring an additional 948,902 shares during the period. FMR LLC increased its holdings in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $313,769,000. Wilmington Savings Fund Society FSB lifted its holdings in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the period. Finally, Vanguard Group Inc. grew its position in Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. BTIG Research increased their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Barclays upped their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $508.58 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a 50-day simple moving average of $561.62 and a 200-day simple moving average of $532.25. The stock has a market capitalization of $181.15 billion, a P/E ratio of 79.34, a PEG ratio of 5.85 and a beta of 1.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.